Pre-hospital reduced-dose fibrinolysis coupled with urgent percutaneous coronary intervention reduces time to reperfusion and improves angiographic perfusion score compared with prehospital fibrinolysis alone or primary percutaneous coronary intervention: results of the PATCAR Pilot Trial

J Am Coll Cardiol. 2007 Oct 16;50(16):1612-4. doi: 10.1016/j.jacc.2007.07.020. Epub 2007 Oct 1.

Authors

Richard W Smalling, Gregory M Giesler, Vinay R Julapalli, Ali E Denktas, Stefano M Sdringola, Mary T Vooletich, James J McCarthy, Richard N Bradley, David E Persse, Bonnie K Richter, Masahiro Yagi, Kenichi Fujise, H Vernon Anderson

PMID: 17936164
DOI: 10.1016/j.jacc.2007.07.020

No abstract available

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Angioplasty, Balloon, Coronary*
Aspirin / administration & dosage
Coronary Angiography
Coronary Circulation
Dose-Response Relationship, Drug
Electrocardiography
Emergency Medical Services*
Feasibility Studies
Fibrinolytic Agents / administration & dosage
Heparin / administration & dosage
Humans
Myocardial Infarction / therapy*
Myocardial Reperfusion*
Pilot Projects
Prospective Studies
Thrombolytic Therapy / methods*
Time Factors

Substances

Fibrinolytic Agents
Heparin
Aspirin